Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation
Public ClinicalTrials.gov record NCT04773678. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Efficacy and Safety Study of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the efficacy, safety of two dose levels of CBP-201 in patients with moderate to severe persistent asthma with Type 2 inflammation.
Study identification
- NCT ID
- NCT04773678
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 322 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 11, 2021 (Actual)
- Primary completion
- Aug 5, 2023 (Actual)
- Completion
- Sep 28, 2023 (Actual)
- Last update posted
- Mar 29, 2024
2021 – 2023
United States locations
- U.S. sites
- 39
- U.S. states
- 16
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Connect Investigative Site 154 | Tucson | Arizona | 85704 | — |
| Connect Investigative Site 109 | Huntington Beach | California | 92647 | — |
| Connect Investigative Site 143 | Huntington Beach | California | 92647 | — |
| Connect Investigative Site 132 | Lancaster | California | 93534 | — |
| Connect Investigative Site 125 | Mission Viejo | California | 92691 | — |
| Connect Investigative Site 103 | San Jose | California | 95117 | — |
| Connect Investigative Site 161 | Hialeah | Florida | 33012 | — |
| Connect Investigative Site 114 | Hollywood | Florida | 33021 | — |
| Connect Investigative Site 142 | Leesburg | Florida | 34748 | — |
| Connect Investigative Site 104 | Miami | Florida | 33126 | — |
| Connect Investigative Site 166 | Miami | Florida | 33145 | — |
| Connect Investigative Site 118 | Miami | Florida | 33155 | — |
| Connect Investigative Site 162 | Miami | Florida | 33155 | — |
| Connect Investigative Site 163 | Miami | Florida | 33174 | — |
| Connect Investigative Site 164 | Miami | Florida | 33174 | — |
| Connect Investigative Site 105 | Miami | Florida | 33176 | — |
| Connect Investigative Site 165 | Miami Gardens | Florida | 33014 | — |
| Connect Investigative Site 110 | Miami Lakes | Florida | 33014 | — |
| Connect Investigative Site 123 | Winter Park | Florida | 32789 | — |
| Connect Investigative Site 124 | Bangor | Maine | 04401 | — |
| Connect Investigative Site 120 | White Marsh | Maryland | 21162 | — |
| Connect Investigative Site 146 | West Bloomfield | Michigan | 48322 | — |
| Connect Investigative Site 112 | St Louis | Missouri | 63141 | — |
| Connect Investigative Site 119 | Bellevue | Nebraska | 78759 | — |
| Connect Investigative Site 144 | North Las Vegas | Nevada | 89030 | — |
| Connect Investigative Site 111 | Princeton | New Jersey | 08540 | — |
| Connect Investigative Site 117 | Buffalo | New York | 14201 | — |
| Connect Investigative Site 153 | New York | New York | 10036 | — |
| Connect Investigative Site 122 | Winston-Salem | North Carolina | 27104 | — |
| Connect Investigative Site 136 | Cincinnati | Ohio | 45236 | — |
| Connect Investigative Site 147 | Toledo | Ohio | 43617 | — |
| Connect Investigative Site 107 | Edmond | Oklahoma | 73034 | — |
| Connect Investigative Site 149 | Oklahoma City | Oklahoma | 73120 | — |
| Connect Investigative Site 129 | Warwick | Rhode Island | 02886 | — |
| Connect Investigative Site 116 | Austin | Texas | 78759 | — |
| Connect Investigative Site 102 | Boerne | Texas | 78006 | — |
| Connect Investigative Site 121 | Dallas | Texas | 75231 | — |
| Connect Investigative Site 108 | El Paso | Texas | 79903 | — |
| Connect Investigative Site 150 | Katy | Texas | 77450 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04773678, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2024 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04773678 live on ClinicalTrials.gov.